We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report.
- Authors
TRAVE, Ilaria; SALVI, Ilaria; BAGNASCO, Diego; PARODI, Aurora; COZZANI, Emanuele
- Abstract
The article discusses a case report of a 77-year-old woman with atopic dermatitis and asthma who developed hypereosinophilia while being treated with dupilumab. The patient's condition improved after switching to tralokinumab, which targets interleukin-13. Tralokinumab was found to be effective in controlling the symptoms of atopic dermatitis and asthma without causing hypereosinophilia. The study highlights the potential of tralokinumab as an alternative treatment for patients with atopic dermatitis and asthma who develop hypereosinophilia.
- Subjects
BLOOD cell count; FORCED expiratory volume; ASTHMATICS; CELL adhesion molecules; EOSINOPHILIC esophagitis
- Publication
Acta Dermato-Venereologica, 2024, Vol 104, p1
- ISSN
0001-5555
- Publication type
Academic Journal
- DOI
10.2340/actadv.v104.40800